NANO CAP NEW MILLENNIUM GROWTH FUND L P
Position in KLRS — Kalaris Therapeutics, Inc.
CIK 1277890
STATEN ISLAND, NY
Position in KLRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$50,875
+$27,795 QoQ
Shares Held
12,500
+212.5% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#41
of 57 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KLRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NANO CAP NEW MILLENNIUM GROWTH FUND L P holds $8,529,385 across 23 Biotechnology names. KLRS ranks #22 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SEER |
Seer, Inc.
|
825,000 | $1,369,500 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
20,500 | $1,118,070 | |
| 3 | JANX |
Janux Therapeutics, Inc.
|
56,000 | $860,160 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
19,500 | $726,765 | |
| 5 | KYTX |
Kyverna Therapeutics, Inc.
|
70,000 | $623,700 | |
| 6 | ALEC |
Alector, Inc.
|
200,000 | $402,000 | |
| 7 | NKTX |
Nkarta, Inc.
|
130,000 | $367,900 | |
| 8 | BCYC |
Bicycle Therapeutics PLC
|
80,000 | $339,200 |
All Filings in KLRS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,875 | 12,500 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $23,080 | 4,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $33,760 | 4,000 | Shares | Sole | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||